Singh AK, Singh A, Singh R, Misra A (2023) Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials
Estimated difference in HbA1c reduction between CagriSema and cagrilintide was statistically significant: -1.3 Percentage (95 Percentage CI, -1.7 to -0.8
Some researchers wonder if they can take tirzepatide a day early or take their GLP-1 a day early
In addition, preclinical data suggest that GLP-1 agonists may have anti-inflammatory, immunoregulatory, and chondroprotective effects, potentially benefiting OA patients. According to Wright, further analysis is necessary to understand if these medications can truly impact OA patients beyond pain management
If you have never used a GLP-1 medication in any form, you can begin directly with Foundayo